Medicines

  1. Cotellic (cobimetinib)
    Cotellic (cobimetinib)
    by Roche Registration GmbH
    for Skin Cancer
    €5,970.00
  2. Darzalex (daratumumab)
    Darzalex (daratumumab)
    by Janssen-Cilag International N.V.
    for Multiple Myeloma
    €571.20
  3. Descovy (emtricitabine/tenofovir alafenamide)
    Descovy (emtricitabine/tenofovir alafenamide)
    by Gilead Sciences International Limited
    for HIV/AIDS
    €694.80
  4. Empliciti (elotuzumab)
    Empliciti (elotuzumab)
    by Bristol-Myers Squibb
    for Multiple Myeloma
    €1,299.76
  5. Fycompa (perampanel)
    Fycompa (perampanel)
    by Eisai Europe Ltd
    for Epilepsy
    €114.00
  6. Ibrance (palbociclib)
    Ibrance (palbociclib)
    by Pfizer Limited
    for Breast Cancer
    €2,780.00
  7. Imfinzi (durvalumab)
    Imfinzi (durvalumab)
    by AstraZeneca Pharmaceuticals LP
    for Urothelial Carcinoma, Lung Cancer
    €790.20
  8. Kevzara (sarilumab)
    Kevzara (sarilumab)
    by Sanofi - Aventis Groupe
    for Rheumatoid Arthritis
    €1,490.00
  9. Keytruda (pembrolizumab)
    Keytruda (pembrolizumab)
    by Merck Sharp
    for Urothelial Carcinoma, Gastric Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Skin Cancer
    €2,796.00
View as Grid List

Items 37-45 of 72

per page
Set Descending Direction